BEOVU brolucizumab (rbe) 120 mg/mL solution for injection in vial

Approval Id: 2dec3446e78f1d2a
Product Name: BEOVU brolucizumab (rbe) 120 mg/mL solution for injection in vial
Artg Id: 313680
Artg Name: BEOVU brolucizumab (rbe) 120 mg/mL solution for injection in vial
Sponsor: Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date: 2020-01-16
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Product Information: https://medical-cdn.nocode.com/drug_tga/3d979f1621ac96e1327b2387969928db.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

2dec3446e78f1d2a

Type

Standard